Ken Fisher Becton Dickinson & CO Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fisher Asset Management, LLC holds 1,083 shares of BDX stock, worth $240,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,083

Previous 1,990 45.58%

Holding current value

$240,404

Previous $465,000 43.87%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$221.47 - $242.41 $200,873 - $219,865	-907 Reduced 45.58%	1,083 $261,000
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $182,531 - $199,643	811 Added 68.79%	1,990 $465,000
Q1 2024 May 09, 2024	SELL	$233.45 - $247.73 $26,379 - $27,993	-113 Reduced 8.75%	1,179 $291,000
Q4 2023 Mar 05, 2024	SELL	$232.24 - $267.23 $23,224 - $26,723	-100 Reduced 7.18%	1,292 $315,000
Q4 2023 Feb 06, 2024	SELL	$232.24 - $267.23 $264,056 - $303,840	-1,137 Reduced 44.96%	1,392 $339,000
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $268,409 - $298,620	1,053 Added 71.34%	2,529 $653,000
Q2 2023 Dec 12, 2023	SELL	$238.39 - $265.32 $251,024 - $279,381	-1,053 Reduced 41.64%	1,476 $389,000
Q2 2023 Aug 08, 2023	BUY	$238.39 - $265.32 $117,764 - $131,068	494 Added 50.31%	1,476 $390,000
Q1 2023 Dec 12, 2023	SELL	$229.71 - $259.35 $355,361 - $401,214	-1,547 Reduced 61.17%	982 $243,000
Q1 2023 May 01, 2023	SELL	$229.71 - $259.35 $118,760 - $134,083	-517 Reduced 34.49%	982 $243,000
Q4 2022 Feb 03, 2023	BUY	$218.29 - $256.91 $102,378 - $120,490	469 Added 45.53%	1,499 $381,000
Q3 2022 Nov 08, 2022	SELL	$51.03 - $264.23 $6,276 - $32,500	-123 Reduced 10.67%	1,030 $230,000
Q2 2022 Aug 09, 2022	BUY	$234.74 - $275.42 $44,835 - $52,605	191 Added 19.85%	1,153 $284,000
Q1 2022 May 05, 2022	SELL	$243.64 - $270.48 $30,455 - $33,810	-125 Reduced 11.5%	962 $256,000
Q4 2021 Feb 02, 2022	BUY	$230.08 - $250.94 $21,397 - $23,337	93 Added 9.36%	1,087 $273,000
Q3 2021 Oct 26, 2021	SELL	$232.72 - $256.47 $30,951 - $34,110	-133 Reduced 11.8%	994 $244,000
Q2 2021 Jul 27, 2021	BUY	$232.65 - $254.58 $44,901 - $49,133	193 Added 20.66%	1,127 $274,000
Q1 2021 Apr 27, 2021	SELL	$232.09 - $256.88 $242,069 - $267,925	-1,043 Reduced 52.76%	934 $227,000
Q4 2020 Jan 29, 2021	BUY	$221.92 - $245.94 $218,369 - $242,004	984 Added 99.09%	1,977 $495,000
Q3 2020 Nov 10, 2020	BUY	$215.77 - $276.76 $214,259 - $274,822	993 New	993 $231,000
Q1 2020 Apr 28, 2020	SELL	$195.69 - $279.01 $281,010 - $400,658	-1,436 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$236.45 - $266.82 $17,733 - $20,011	-75 Reduced 4.96%	1,436 $391,000
Q3 2019 Oct 29, 2019	SELL	$230.58 - $256.08 $49,805 - $55,313	-216 Reduced 12.51%	1,511 $382,000
Q2 2019 Jul 30, 2019	BUY	$217.4 - $246.08 $15,218 - $17,225	70 Added 4.22%	1,727 $435,000
Q1 2019 Apr 22, 2019	SELL	$206.05 - $248.17 $85,510 - $102,990	-415 Reduced 20.03%	1,657 $414,000
Q4 2018 Jan 25, 2019	SELL	$204.73 - $257.93 $8,598 - $10,833	-42 Reduced 1.99%	2,072 $467,000
Q3 2018 Oct 24, 2018	SELL	$233.07 - $256.0 $3,496 - $3,840	-15 Reduced 0.7%	2,114 $552,000
Q2 2018 Jul 09, 2018	SELL	$208.1 - $233.85 $29,758 - $33,440	-143 Reduced 6.29%	2,129 $510,000
Q1 2018 May 11, 2018	SELL	$205.46 - $240.27 $41,297 - $48,294	-201 Reduced 8.13%	2,272 $492,000
Q1 2018 Apr 19, 2018	BUY	$205.46 - $240.27 $22,806 - $26,669	111 Added 4.7%	2,473 $536,000
Q4 2017 Jan 24, 2018	BUY	$189.0 - $222.64 $4,158 - $4,898	22 Added 0.94%	2,362 $506,000
Q3 2017 Oct 17, 2017	BUY	$186.89 - $198.9 $437,322 - $465,426	2,340	2,340 $459,000

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account